🫁 Revised Geneva Score (PE Probability)
UseAn entirely objective alternative to Wells for suspected PE.
Strata0–3 low, 4–10 intermediate, ≥ 11 high. Non-high probability → high-sensitivity D-dimer; high → CT pulmonary a…
LimitsObjective inputs reduce inter-rater variability but still need accura… · Pair with age-adjusted or YEARS strategies per local protocol. · High probability should not be deferred for D-dimer alone.
SourceLe Gal G, et al. Ann Intern Med 2006; 2019 ESC/ERS acute PE guideline; China PTE guideline 2025
This-shift next steps
After scoring: open the scene pack, peer scores, and the matching pathway. Local reference — no HIS write.
- Who it is for
- Adults with suspected acute PE when deciding whether to test further, and risk stratification after confirmation.
- Who it is not for
- PERC must not rule out PE when clinical probability is not already low. Confirmed PE does not return to PERC. PERC is not an atrial-fibrillation tool and not a treatment page.
- Formula and variables
- Wells PE and revised Geneva estimate clinical probability; the version stays as on this page. PERC is used only when probability is already low, to see whether testing can stop. BOVA is only for normal blood pressure. Hestia only answers outpatient eligibility. No new score.
- Result → next step
- If probability is low and every PERC item is negative, stop further PE testing; otherwise test. The treatment column stays empty before confirmation. After confirmation, duration opens the anticoagulation-duration page. That link is not hung on PERC. Numeric dose waits for age, weight, renal function, and pregnancy.No numeric dose until age, weight, renal function, and pregnancy are all known. Pregnancy is contraindication or caution only.Next step: once acute PE is confirmed on imaging, stratify 30-day mortality risk with PESI →Duration after confirmation →
- Guideline and review date
- 2019 ESC/ERS PE; China PTE guideline 2025 · reviewed 2026-10-06
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.
Methodology · worked example, guidelines & full notes
Uses only objective variables, reducing inter-rater variability.
When to use
An entirely objective alternative to Wells for suspected PE.
How it works
Weighted items (prior VTE 3, leg pain 3, HR 75–94 3 / ≥95 5, surgery/fracture 2, malignancy 2, haemoptysis 2, age >65 1, palpation pain + oedema 4). 0–3 low, 4–10 intermediate, ≥11 high.
Key points
- Uses only objective variables, reducing inter-rater variability.
- Non-high probability → high-sensitivity D-dimer.
- High probability → CT pulmonary angiography.
References
- [Original paper / primary source]Le Gal G, et al. Ann Intern Med 2006; 2019 ESC/ERS acute PE guideline; China PTE guideline 2025
- [Guideline basis]Guideline source: 2019 ESC/ERS Guidelines for the diagnosis and management of acute pulmonary embolism (Konstantinides SV, et al. Eur Heart J 2020;41(4):543–603. doi:10.1093/eurheartj/ehz405); Chinese guidelines for the diagnosis, treatment, prophylaxis and management of pulmonary thromboembolism, 2025 edition (Natl Med J China 2025;105(26):2162–2194. doi:10.3760/cma.j.cn112137-20250509-01141). Original derivation: Le Gal G, et al. Ann Intern Med 2006;144(3):165–171. doi:10.7326/0003-4819-144-3-200602070-00004.
- [Guideline basis]US layer: 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults (Creager MA, et al. Circulation 2026;153(12):e977-e1051. doi:10.1161/CIR.0000000000001415; simultaneous JACC publication J Am Coll Cardiol 2026;87(13):1626-1710. doi:10.1016/j.jacc.2025.11.005). It lists the revised Geneva score with Wells and PERC as pretest-probability tools, combined with an age-adjusted D-dimer or the YEARS strategy and CTPA in the diagnostic pathway. This page still scores the original Le Gal 2006 revised Geneva; thresholds are unchanged and the European layer remains ESC 2019.
Worked calculation
The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.
| Age > 65 | No |
|---|---|
| Previous DVT/PE | No |
| Surgery/fracture within 1 month | No |
| Active malignancy | No |
| Unilateral lower-limb pain | No |
| Haemoptysis | No |
| Heart rate | 75–94 (3) |
| Pain on deep vein palpation + unilateral oedema | No |
→Revised Geneva3
- Probability：Low (~8% PE)
- Pathway：Non-high probability → high-sensitivity D-dimer; if negative, PE excluded.
| Age > 65 | No |
|---|---|
| Previous DVT/PE | No |
| Surgery/fracture within 1 month | No |
| Active malignancy | No |
| Unilateral lower-limb pain | No |
| Haemoptysis | No |
| Heart rate | < 75 (0) |
| Pain on deep vein palpation + unilateral oedema | No |
→Revised Geneva0
- Probability：Low (~8% PE)
- Pathway：Non-high probability → high-sensitivity D-dimer; if negative, PE excluded.
Verification & sources · governance
FAQ
Frequently asked questions
- Does Revised Geneva Score (PE Probability) upload patient data? Where is it calculated?
- Calculation runs locally in the browser; inputs and results are not uploaded. For licensed clinicians only; interpret with history, investigations and local protocols — not a diagnosis or prescription.
- How is Revised Geneva Score (PE Probability) calculated in practice? Can you show a worked example?
- Inputs: Age > 65 No, Previous DVT/PE No, Surgery/fracture within 1 month No, Active malignancy No, Unilateral lower-limb pain No, Haemoptysis No, Heart rate 75–94 (3), Pain on deep vein palpation + unilateral oedema No → Result: Revised Geneva 3（Probability: Low (~8% PE), Pathway: Non-high probability → high-sensitivity D-dimer; if negative, PE excluded.） Inputs: Age > 65 No, Previous DVT/PE No, Surgery/fracture within 1 month No, Active malignancy No, Unilateral lower-limb pain No, Haemoptysis No, Heart rate < 75 (0), Pain on deep vein palpation + unilateral oedema No → Result: Revised Geneva 0（Probability: Low (~8% PE), Pathway: Non-high probability → high-sensitivity D-dimer; if negative, PE excluded.）